Viridian Therapeutics, Inc.\DE
Pharmaceutical company · Waltham, Massachusetts, United States · Nasdaq: VRDN
Viridian Therapeutics, Inc.\DE is a pharmaceutical company headquartered in Waltham, Massachusetts, United States. Its earliest recorded incorporation is in 2006. Its shares trade on Nasdaq under the ticker VRDN. It has reported private securities offerings to the US SEC, most recently $91 million sold in a notice filed in 2020.
What does Viridian Therapeutics, Inc.\DE do?
Private fundraising reported to the SEC
13 Form D notices; the most recent reported $91 million sold (2020).
Frequently asked questions about Viridian Therapeutics, Inc.\DE
Where is Viridian Therapeutics, Inc.\DE headquartered?
Viridian Therapeutics, Inc.\DE is headquartered in Waltham, Massachusetts, United States.
What does Viridian Therapeutics, Inc.\DE do?
Viridian Therapeutics, Inc.\DE is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Viridian Therapeutics, Inc.\DE a public company?
Yes. Viridian Therapeutics, Inc.\DE trades on Nasdaq under the ticker VRDN.
When was Viridian Therapeutics, Inc.\DE founded?
The earliest incorporation on record for Viridian Therapeutics, Inc.\DE is in 2006, according to public company registers.
Similar companies
- Mustang Bio, Inc.Waltham, Massachusetts, United States
- Alkermes IncWaltham, Massachusetts, United States
- Spyre Therapeutics, Inc.Waltham, Massachusetts, United States
- Cogent Biosciences, Inc.Waltham, Massachusetts, United States
- Dyne Therapeutics, Inc.Waltham, Massachusetts, United States
- Korsana Biosciences, Inc.Waltham, Massachusetts, United States
- Jade Biosciences, Inc.Waltham, Massachusetts, United States
- Werewolf Therapeutics, Inc.Waltham, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.